What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT.

Rafiyah KhanAlan UrenLuke CanhamDavid CottrellMarcus J DrakeNikki Cotterill

Published in: Multiple sclerosis international (2018)

This qualitative exploration revealed an association between nocturia and increased levels of fatigue during the day by those with MS. However, perspectives towards the effectiveness of melatonin as a potential treatment varied as both placebo and melatonin were perceived as having very similar effects.

Keyphrases

multiple sclerosis
systematic review
mass spectrometry
depressive symptoms
clinical trial
ms ms
lower urinary tract symptoms
social support
benign prostatic hyperplasia
white matter
climate change